FIELD: medicine; biology.
SUBSTANCE: invention refers to medical-biological, pathophysiological science and concerns modeling of endothelial dysfunction and pathology of internal organs accompanying experimental intoxication syndrome combined with L-NAME. For this purpose, metabolic disorders are reproduced by administering parenteral exposure of nickel chloride in dose of 0.5 mg/kg of animals weight once a day to experimental animals for 30 days, as well as in combination with nickel chloride, additionally parenteral inhibitor of enzyme – endothelial NO-synthase, producing nitrogen oxide, – L-NAME 25 mg/kg of animal weight once day for 30 days is introduced.
EFFECT: invention provides higher accuracy and adequacy of examining pathogenetic mechanisms of endothelial dysfunction formation and character of metabolic changes in blood and internal organs, as well as higher efficiency, reproducibility, convenience, accessibility, safety and low cost of experiments.
1 cl, 3 dwg, 2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF DETERMINING EFFECTIVENESS OF TREATMENT OF ENDOTHELIAL DYSFUNCTION IN METABOLIC AND FUNCTIONAL DISORDERS IN EXPERIMENTAL RATS | 2023 |
|
RU2808420C1 |
METHOD FOR DIAGNOSING ENDOTHELIAL DYSFUNCTION IN METABOLIC AND FUNCTIONAL DISORDERS | 2022 |
|
RU2790368C1 |
METHOD FOR CORRECTION OF OXIDATIVE STRESS AND NO PRODUCING ENDOTHELIAL DYSFUNCTION ACCOMPANYING VASCULAR COMPLICATIONS OF DIABETES MELLITUS IN EXPERIMENT | 2013 |
|
RU2521279C1 |
USE OF OXATHRIAZOLO-5-OLATE FOR TREATING SEXUAL DISORDERS | 2014 |
|
RU2600845C2 |
METHOD OF DIAGNOSING AND TREATING ENDOTHELIAL DYSFUNCTION IN METABOLIC DISORDERS IN PATIENTS WITH ISCHEMIC HEART DISEASE OF SECOND FUNCTIONAL CLASS | 2020 |
|
RU2737416C1 |
METHOD FOR SIMULATION OF ENDOTHELIAL DYSFUNCTION ASSOCIATED WITH LOW GRADATION SYSTEMIC INFLAMMATION AND OXIDATIVE STRESS | 2016 |
|
RU2618657C1 |
METHOD OF CORRECTION OF ENDOTHELIAL DYSFUNCTION USING MODEL OF L-NAME-INDUCED NITRIC OXIDE DEFICIENCY | 2023 |
|
RU2810415C1 |
COMPOSITION POSSESSING ENDOTHELIAL PROTECTIVE, VASODILATING AND ANGIOPROTECTIVE EFFECT | 2011 |
|
RU2464019C1 |
DIAGNOSTIC TECHNIQUE AND METHOD OF ENDOTHELIAL DYSFUNCTION CORRECTION IN VASCULAR COMPLICATIONS OF ALLOXAN DIABETES IN EXPERIMENT | 2010 |
|
RU2455702C1 |
METHOD FOR ESTIMATING EFFICIENCY OF ENDOTHELIOTROPIC THERAPY AFTER RECONSTRUCTIVE OPERATIONS ON ARTERIES | 2015 |
|
RU2611386C2 |
Authors
Dates
2020-01-24—Published
2019-08-07—Filed